A Study of LY3025876 in Healthy Volunteers

Lilly

Status and phase

Completed

Phase 1

Conditions

Healthy Volunteers

Treatments

Drug: LY3025876

Drug: Placebo

Study type

Interventional

Funder types

Industry

Identifiers

NCT01528124

14346

I6D-FW-SMRA (Other Identifier)

Details and patient eligibility

About

This trial is conducted in Singapore. The aim of this trial is to evaluate the safety and tolerability of the study drug in healthy people and investigate how much of the study drug gets into the blood stream and how long it takes the body to get rid of it. Information about any side effects that may occur will also be collected.

Enrollment

41 patients

Sex

All

Ages

21 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Must be either a healthy male or a healthy female who cannot become pregnant
Have a body mass index (BMI) of 18.5 to 40.0 kilograms per meter squared (kg/m^2), inclusive, at screening

Exclusion criteria

Are allergic to LY3025876 or related compounds
Have a history of significant disease that may affect the actions of drugs or may pose a risk when taking the study medication
Have a history of developing allergies, asthma, severe drug allergies (symptoms including, but not limited to, itching, red rashes, sores on the skin, scaling and shedding of skin), allergies or reactions to more than one drug, or have had bad reactions to skin creams containing corticosteroids. Corticosteroids are mainly used to control inflammation.